BSE filing, NSE: ADVIKLA. Summary written from the filing by ALFA Finder's alert engine.
MPS Pharma Ltd: key numbers
- Share price
- ₹2.08
- Market cap
- ₹3.98 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.02 Cr
- P/E (TTM)
- -3.8×Sector 45.9×
- Promoter holding
- 35.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from MPS Pharma Ltd
All →Advik Laboratories Other Announcement
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
Advik Laboratories Annual General Meeting
MPS Pharmaa Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of audited financial statements and director appointments.
Advik Laboratories Other Announcement
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
Advik Laboratories Annual General Meeting
The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.
Advik Laboratories Board Meeting Outcome
MPS Pharmaa Ltd announced the outcome of its board meeting, fixing the 32nd AGM date and recommending new director and auditor appointments for shareholder approval.
Advik Laboratories Board Meeting Date
MPS Pharmaa Limited has scheduled a board meeting on September 02, 2026, to consider the notice for the company's upcoming Annual General Meeting.
Other management change announcements
All →REC Management Change
REC Limited intimated that Executive Director J.K. Nayak ceased to hold that role effective 30 October 2026. He was appointed Chairman & Managing Director of IREDA.
Himadri Speciality Chemical Management Change
Himadri Speciality Chemical's board revised its senior management list following organisational restructuring. Six personnel are listed, including the CFO and Company Secretary.
HMT Management Change
HMT Ltd intimated the resignation of Aparna R, Assistant General Manager (F&A), who ceases as CFO and KMP effective close of business on October 30, 2026. Her resignation letter is attached.
Share India Securities Management Change
Share India Securities appointed Krishan Singh Barguzar as Non-Executive Independent Director for 36 months, effective 30 October 2026. He is a former SBI Chief General Manager.
Indian Renewable Energy Development Agency Management Change
IREDA appointed Jatin Kumar Nayak as CMD effective October 30, 2026. Dr. Bijay Kumar Mohanty ceased to hold the additional CMD charge that day.
Kwality Wall's (India) Management Change
Kwality Wall's appointed Tahir Toloy Tanridagli as MD and CEO for three years from November 1, 2026. Vivek Sarbhai ceases as Senior Management Personnel from October 31.
- Execution
- 3 years (1 November 2026 to 31 October 2029)